Articles tagged with “reimbursement”

An overview of market access analytics covering its definition, scope, and role in helping pharmaceutical firms navigate complex payer reimbursement models. Updated for 2026 with IRA drug price negotiation impacts, agentic AI platforms, EU HTA harmonisation, and digital therapeutics reimbursement advances.

Practical guide for Market Access teams and field representatives on handling common payer objections in oncology, including strategies for verbal and written communications, real-world examples, and response frameworks.